Tg Therapeutics reported $-66796000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Amgen AMGN:US $ 3341M 185M
Ardelyx ARDX:US $ -27.58M 4.9M
Arrowhead Research ARWR:US $ 44.15M 104.9M
Biogen BIIB:US $ 674.7M 20.2M
Corcept Therapeutics CORT:US $ 27.06M 9.9M
Curis CRIS:US $ -15.1M 2.57M
Dynavax Technologies DVAX:US $ 32.46M 49.7M
Gilead Sciences GILD:US $ 3422M 1947M
Infinity Pharmaceuticals INFI:US $ -12.29M 0.91M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
Johnson & Johnson JNJ:US $ 9309M 1549M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Novartis NOVN:VX SF 4552M 346M
Novavax NVAX:US $ 216.06M 1037.12M
Ptc Therapeutics PTCT:US $ -60.21M 5.71M
Puma Biotechnology PBYI:US $ 1.52M 7.59M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Spectrum Pharmaceuticals SPPI:US $ -13.99M 22.79M
Tg Therapeutics TGTX:US $ -66.8M 26.07M
Verastem VSTM:US $ -16.95M 0.47M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M
Ziopharm Oncology ZIOP:US $ -8.4M 1.21M